Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,540,000
Closed -$3.78M 80
2026
Q1
$3.78M Sell
2,540,000
-8,780,000
-78% -$13.3M 0.11% 78
2025
Q4
$14.9M Sell
11,320,000
-5,905,000
-34% -$7.41M 0.51% 43
2025
Q3
$23.6M Sell
17,225,000
-6,550,000
-28% -$8.72M 1.07% 35
2025
Q2
$33.5M Buy
23,775,000
+1,769,660
+8% +$2.51M 1.77% 21
2025
Q1
$35M Buy
22,005,340
+11,005,340
+100% +$26.8M 2.5% 12
2024
Q4
$38.9M Buy
11,000,000
+9,950,000
+948% +$39.7M 2.31% 15
2024
Q3
$4.77M Buy
+1,050,000
New +$4.77M 0.36% 50
2024
Q2
Sell
-2,200,000
Closed -$7.26M 68
2024
Q1
$7.26M Buy
+2,200,000
New +$4.93M 0.6% 34

Other funds holding GERN

Vestal Point Capital's GERN Position: Q2 2026 in Review

Vestal Point Capital sold out of Geron (GERN) in Q2 2026, closing a stake of 2,540,000 shares — an estimated $3.78M sold.

Vestal Point Capital first reported a position in GERN in Q1 2024 and held it in 8 quarters. The position peaked at $38.9M in Q4 2024. 259 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • Vestal Point Capital reported no remaining Geron position as of Q2 2026 after selling out during the quarter.
  • Vestal Point Capital sold 2,540,000 Geron shares in Q2 2026, an estimated $3.78M.
  • Vestal Point Capital first reported a position in Geron in Q1 2024 and held it in 8 quarters.
  • Vestal Point Capital's Geron position peaked at $38.9M in Q4 2024.
  • 259 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on Vestal Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.